Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Leukotriene-mediated neuroinflammation, toxic brain damage, and neurodegeneration in acute methanol poisoning

S. Zakharov, K. Kotikova, O. Nurieva, J. Hlusicka, P. Kacer, P. Urban, M. Vaneckova, Z. Seidl, P. Diblik, P. Kuthan, T. Navratil, D. Pelclova,

. 2017 ; 55 (4) : 249-259. [pub] 20170206

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17013271

Grantová podpora
NV16-27075A MZ0 CEP - Centrální evidence projektů

CONTEXT: The role of neuroinflammation in methanol-induced toxic brain damage has not been studied. OBJECTIVE: We studied acute concentrations and the dynamics of leukotrienes (LT) in serum in hospitalized patients with acute methanol poisoning and in survivors. METHODS: Series of acute cysteinyl-LT and LTB4 concentration measurements were performed in 28/101 hospitalized patients (mean observation time: 88 ± 20 h). In 36 survivors, control LT measurements were performed 2 years after discharge. RESULTS: The acute maximum (Cmax) LT concentrations were higher than concentrations in survivors: Cmax for LTC4 was 80.7 ± 5.6 versus 47.9 ± 4.5 pg/mL; for LTD4, 51.0 ± 6.6 versus 23.1 ± 2.1 pg/mL; for LTE4, 64.2 ± 6.0 versus 26.2 ± 3.9 pg/mL; for LTB4, 59.8 ± 6.2 versus 27.2 ± 1.4 pg/mL (all p < 0.001). The patients who survived had higher LT concentrations than those who died (all p < 0.01). Among survivors, patients with CNS sequelae had lower LTE4 and LTB4 than did those without sequelae (both p < 0.05). The LT concentrations increased at a rate of 0.4-0.5 pg/mL/h and peaked 4-5 days after admission. The patients with better outcomes had higher cys-LTs (all p < 0.01) and LTB4 (p < 0.05). More severely poisoned patients had lower acute LT concentrations than those with minor acidemia. The follow-up LT concentrations in survivors with and without CNS sequelae did not differ (all p > 0.05). The mean decrease in LT concentration was 30.9 ± 9.0 pg/mL for LTC4, 26.3 ± 8.6 pg/mL for LTD4, 37.3 ± 6.4 pg/mL for LTE4, and 32.0 ± 8.8 pg/mL for LTB4. CONCLUSIONS: Our findings suggest that leukotriene-mediated neuroinflammation may play an important role in the mechanisms of toxic brain damage in acute methanol poisoning in humans. Acute elevation of LT concentrations was moderate, transitory, and was not followed by chronic neuroinflammation in survivors.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013271
003      
CZ-PrNML
005      
20170428110812.0
007      
ta
008      
170413s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/15563650.2017.1284332 $2 doi
035    __
$a (PubMed)28165820
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Zakharov, Sergey $u a Department of Occupational Medicine, First Faculty of Medicine , Charles University , Prague , Czech Republic. b Toxicological Information Centre, General University Hospital , Prague , Czech Republic.
245    10
$a Leukotriene-mediated neuroinflammation, toxic brain damage, and neurodegeneration in acute methanol poisoning / $c S. Zakharov, K. Kotikova, O. Nurieva, J. Hlusicka, P. Kacer, P. Urban, M. Vaneckova, Z. Seidl, P. Diblik, P. Kuthan, T. Navratil, D. Pelclova,
520    9_
$a CONTEXT: The role of neuroinflammation in methanol-induced toxic brain damage has not been studied. OBJECTIVE: We studied acute concentrations and the dynamics of leukotrienes (LT) in serum in hospitalized patients with acute methanol poisoning and in survivors. METHODS: Series of acute cysteinyl-LT and LTB4 concentration measurements were performed in 28/101 hospitalized patients (mean observation time: 88 ± 20 h). In 36 survivors, control LT measurements were performed 2 years after discharge. RESULTS: The acute maximum (Cmax) LT concentrations were higher than concentrations in survivors: Cmax for LTC4 was 80.7 ± 5.6 versus 47.9 ± 4.5 pg/mL; for LTD4, 51.0 ± 6.6 versus 23.1 ± 2.1 pg/mL; for LTE4, 64.2 ± 6.0 versus 26.2 ± 3.9 pg/mL; for LTB4, 59.8 ± 6.2 versus 27.2 ± 1.4 pg/mL (all p < 0.001). The patients who survived had higher LT concentrations than those who died (all p < 0.01). Among survivors, patients with CNS sequelae had lower LTE4 and LTB4 than did those without sequelae (both p < 0.05). The LT concentrations increased at a rate of 0.4-0.5 pg/mL/h and peaked 4-5 days after admission. The patients with better outcomes had higher cys-LTs (all p < 0.01) and LTB4 (p < 0.05). More severely poisoned patients had lower acute LT concentrations than those with minor acidemia. The follow-up LT concentrations in survivors with and without CNS sequelae did not differ (all p > 0.05). The mean decrease in LT concentration was 30.9 ± 9.0 pg/mL for LTC4, 26.3 ± 8.6 pg/mL for LTD4, 37.3 ± 6.4 pg/mL for LTE4, and 32.0 ± 8.8 pg/mL for LTB4. CONCLUSIONS: Our findings suggest that leukotriene-mediated neuroinflammation may play an important role in the mechanisms of toxic brain damage in acute methanol poisoning in humans. Acute elevation of LT concentrations was moderate, transitory, and was not followed by chronic neuroinflammation in survivors.
650    _2
$a akutní nemoc $7 D000208
650    _2
$a hydrogenuhličitany $x krev $7 D001639
650    _2
$a krevní glukóza $x metabolismus $7 D001786
650    _2
$a mozek $x účinky léků $x patologie $7 D001921
650    _2
$a kreatinin $x krev $7 D003404
650    _2
$a cystein $x krev $7 D003545
650    _2
$a ethanol $x krev $7 D000431
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a formiáty $x krev $7 D005561
650    _2
$a hospitalizace $7 D006760
650    _2
$a lidé $7 D006801
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a zánět $x chemicky indukované $x patologie $7 D007249
650    _2
$a laktáty $x krev $7 D007773
650    _2
$a leukotrieny $x krev $7 D015289
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methanol $x krev $x otrava $7 D000432
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neurodegenerativní nemoci $x chemicky indukované $x patologie $7 D019636
650    _2
$a otrava $x krev $x farmakoterapie $7 D011041
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kotikova, Katerina $u a Department of Occupational Medicine, First Faculty of Medicine , Charles University , Prague , Czech Republic.
700    1_
$a Nurieva, Olga $u a Department of Occupational Medicine, First Faculty of Medicine , Charles University , Prague , Czech Republic.
700    1_
$a Hlusicka, Jiri $u a Department of Occupational Medicine, First Faculty of Medicine , Charles University , Prague , Czech Republic. b Toxicological Information Centre, General University Hospital , Prague , Czech Republic.
700    1_
$a Kacer, Petr $u c Institute of Chemical Technology , Prague , Czech Republic.
700    1_
$a Urban, Pavel $u a Department of Occupational Medicine, First Faculty of Medicine , Charles University , Prague , Czech Republic. d Centre for Industrial Hygiene and Occupational Medicine, National Institute of Public Health , Prague , Czech Republic.
700    1_
$a Vaneckova, Manuela $u e Department of Radiology, First Faculty of Medicine , Charles University and General University Hospital , Prague , Czech Republic.
700    1_
$a Seidl, Zdenek $u e Department of Radiology, First Faculty of Medicine , Charles University and General University Hospital , Prague , Czech Republic.
700    1_
$a Diblik, Pavel $u f Department of Ophthalmology, First Faculty of Medicine , Charles University and General University Hospital , Prague , Czech Republic.
700    1_
$a Kuthan, Pavel $u f Department of Ophthalmology, First Faculty of Medicine , Charles University and General University Hospital , Prague , Czech Republic.
700    1_
$a Navratil, Tomas $u b Toxicological Information Centre, General University Hospital , Prague , Czech Republic. g Department of Biomimetic Electrochemistry , J. Heyrovský Institute of Physical Chemistry of the AS CR , v.v.i , Prague , Czech Republic.
700    1_
$a Pelclova, Daniela $u a Department of Occupational Medicine, First Faculty of Medicine , Charles University , Prague , Czech Republic. b Toxicological Information Centre, General University Hospital , Prague , Czech Republic.
773    0_
$w MED00013938 $t Clinical toxicology (Philadelphia, Pa.) $x 1556-9519 $g Roč. 55, č. 4 (2017), s. 249-259
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28165820 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170428111133 $b ABA008
999    __
$a ok $b bmc $g 1199736 $s 974049
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 55 $c 4 $d 249-259 $e 20170206 $i 1556-9519 $m Clinical toxicology $n Clin Toxicol (Phila) $x MED00013938
GRA    __
$a NV16-27075A $p MZ0
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...